Feb 21, 2023 | Analysis, Press Releases
New MGA Analysis of the Adalimumab Biosimilars Market in the United States Below is the press release from Biosimilars Council regarding the new report from MGA examining biosimilar competition for Humira (adalimumab) in the US market. Washington, D.C. (February 21,...
Jan 31, 2023 | Interviews
Humira Rivals Set to Try to Drive Down Cost of Blockbuster Drug Celine Castronuovo | Bloomberg Law News “More than 1.4 million patients have used Humira globally, according to AbbVie. The drug takes up a huge chunk of Medicare spending in the US, with an HHS...
Aug 25, 2022 | Interviews
Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat down with CAPD spokesperson Maura Keefe to...
Aug 16, 2022 | Press Releases
New PCMA Podcast Highlights Importance of Prescription Drug Rebates PCMA released the following press release regarding Alex Brill’s interview on the importance of prescription drug rebates. (Washington, D.C.) — The Pharmaceutical Care Management Association’s...